Evaluation and prognostic value of DNA content and of morphometric parameters in malignant mesothelioma using digital image analysis

Lung Cancer

Volumn 14, Issue 2-3, 1996, Pages 229-237

  Segers, Kurt ^a   Singh, Samir Kumar ^a   Van Daele, André ^a   Bogers, Johannes ^a   Van Meerbeeck, Jan ^a   Vermeire, Paul ^a   Weyler, Joost ^a   Van Marck, Eric ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

DNA analysis; Malignant; Mesothelioma; Morphometry; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; DNA CONTENT; DNA DETERMINATION; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; MORPHOMETRICS; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029953727     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-5002(95)00549-8     Document Type: Article

References (31)

1. McDonald J, Armstrong B, Case B et al. Mesothelioma and asbestos fiber type. Evidence from lung tissue analyses. Cancer 1989; 63: 1544-1547.
2. Mossman BT, Bignon J, Corn M et al. Asbestos: scientific developments and implications for public policy. Science 1990; 247: 294-301.
3. Sugarbaker DJ, Mentzer SJ, Strauss G. Extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma. Ann Thorac Surg 1992; 54: 941-946.
4. De Pangher Manzini V, Brollo A, Franceschi S et al. Prognostic factors of malignant mesothelioma of the pleura. Cancer 1993; 72: 410-417.
5. Ruffle P, Feld R, Minkin S et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 322 patients. J Clin Oncol 1989; 7: 1157-1168.
6. Alberts AS, Falkson G, Goedhals L et al. Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers. J Clin Oncol 1988; 6: 527-535.
7. Vindelov LL, Christensen IJ, Jensen G et al. Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis. Results obtained by a set of methods for sample-storage, staining and internal standardization. Cytometry 1983; 3: 332-339.
8. Topalovski M, Hankin RC, Michael C et al. Ploidy analysis of products of conception by image and flow cytometry with cytogenetic correlation. Am J Clin Pathol 1995; 103: 409-414.
9. Lajoie G, Zbieranowski I, Demianiuk C et al. A comparative study of DNA quantitation in breast carcinoma with image cytometric analysis and in vitro fine-needle aspiration with flow cytometric analysis. Am J Clin Pathol 1993; 100: 456-462.
10. Forsslund G, Zetterberg A. Ploidy level determinations in high-grade and low-grade malignant variants of prostatic carcinoma. Cancer Res 1990; 50: 4281-4285.
11. Lukes AS, Kohler MF, Pieper CF et al. Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer. Cancer 1994; 73: 2380-2385.
12. Mir R, Johnson H, Jr, Margolis M et al. Prognostic significance of DNA measurement determined by image analysis in human breast carcinoma. J Surg Oncol 1992; 50: 168-172.
13. Chieco P, Jonker A, Melchiorri C et al. A user's guide for avoiding errors in absorbance image cytometry: a review with original experimental observations. Histochem J 1994; 26: 1-19.
14. Baldock RA, Poole I. Video camera calibration for optical densitometry. J Microsc 1993; 172: 49-54.
15. Opfermann M, Brugal G, Vassilakos P. Cytometry of breast carcinoma: significance of ploidy balance and proliferation index. Cytometry 1987; 8: 217-224.
16. Butchart EJ, Ashcroft T, Barnsley WC et al. Pleural pneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Thorax 1976; 31: 15-24.
17. Pyrhonen S, Laasonen A, Tammilehto L et al. Diploid predominance and prognostic significance of S-phase cells in malignant mesothelioma. Eur J Cancer 1991; 27: 197-200.
18. el-Naggar AK, Ordonez NG, Garnsey L et al. Epithelioid pleural mesotheliomas and pulmonary adenocarcinomas: a comparative DNA flow cytometric study. Hum Pathol 1991; 22: 972-978.
19. Burmer GC, Rabinovitch PS, Kulander BG et al. Flow cytometric analysis of malignant pleural mesotheliomas. Hum Pathol 1989; 20: 777-783.
20. Frierson HF, Jr, Mills SE, Legier JF. Flow cytometric analysis of ploidy in immunohistochemically confirmed examples of malignant epithelial mesothelioma. Am J Clin Pathol 1988; 90: 240-243.
21. Crotty TB, Myers JL, Katzenstein AL et al. Localized malignant mesothelioma. A clinicopathologic and flow cytometric study. Am J Surg Pathol 1994; 18: 357-363.
22. Dejmek A, Stromberg C, Wikstrom B et al. Prognostic importance of the DNA ploidy pattern in malignant mesothelioma of the pleura. Anal Quant Cytol Histol 1992; 14: 217-221.
23. Baak J, Kurver P, Diegenbach P et al. Discrimination of hyperplasia and carcinoma of the endometrium by quantitative microscopy. A feasibility study. Histopathology 1981; 5: 61-68.
24. Uyterlinde AM, Baak JP, Schipper NW et al. Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast-cancer patients with long follow-up. Int J Cancer 1990; 45: 1-7.
25. Gutierrez JL, Val-Bernal JF, Garijo MF et al. Nuclear morphometry in prognosis of renal adenocarcinoma. Urology 1992; 39: 130-134.
26. Aisner J. Current approach to malignant mesothelioma of the pleura. Chest 1995; 107: 332S-344S.
27. Van Meerbeeck JP. Prognostic factors in malignant mesothelioma. Eur Respir J 1994; 7: 1029-1031.
28. Kwee WS, Veldhuizen RW, Golding RP et al. Histologic distinction between malignant mesothelioma, benign pleural lesion and carcinoma metastasis. Evaluation of the application of morphometry combined with histochemistry and immunostaining. Virchows Arch A Pathol Anat Histopathol 1982; 397: 287-299.
29. Bogers JJ, Jacobs W, Segers K et al. Stereological evaluation of malignant mesothelioma versus benign hyperplasia. Pathol Res Pract 1995; 6; 192: 10-14.
30. Hafiz M, Becker R, Mikel U et al. Cytophotometric determination of DNA in mesotheliomas and reactive mesothelial cells. Anal Quant Cytol Histol 1988; 10: 120-126.
31. Tierney G, Wilkinson MJ, Jones JS. The malignancy grading method is not a reliable assessment of malignancy in mesothelioma. J Pathol 1990; 160: 209-211.